<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 01 Feb 2021 06:41:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  15-12B     Prevail Therapeutics                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Prevail+Therapeutics+++++++++++++++++/17891597.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Prevail+Therapeutics+++++++++++++++++/17891597.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Prevail+Therapeutics+++++++++++++++++/17891597.html</guid>
   <pubDate>Mon, 01 Feb 2021 06:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  SC 13G     Prevail Therapeutics                   Filed by: JNE Partners LLP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+JNE+Partners+LLP/17888245.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+JNE+Partners+LLP/17888245.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+JNE+Partners+LLP/17888245.html</guid>
   <pubDate>Fri, 29 Jan 2021 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   Prevail Therapeutics                   Filed by: ORBIMED ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+ORBIMED+ADVISORS+LLC/17883715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+ORBIMED+ADVISORS+LLC/17883715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Prevail+Therapeutics+++++++++++++++++++Filed+by%3A+ORBIMED+ADVISORS+LLC/17883715.html</guid>
   <pubDate>Fri, 29 Jan 2021 06:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Prevail Therapeutics                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Prevail+Therapeutics+++++++++++++++++/17868909.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Prevail+Therapeutics+++++++++++++++++/17868909.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Prevail+Therapeutics+++++++++++++++++/17868909.html</guid>
   <pubDate>Wed, 27 Jan 2021 06:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: ORBIMED ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+ORBIMED+ADVISORS+LLC/17867327.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+ORBIMED+ADVISORS+LLC/17867327.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+ORBIMED+ADVISORS+LLC/17867327.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: Abeliovich Asa</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Abeliovich+Asa/17867311.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Abeliovich+Asa/17867311.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Abeliovich+Asa/17867311.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: Adams Timothy M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Adams+Timothy+M/17867300.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Adams+Timothy+M/17867300.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Adams+Timothy+M/17867300.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: Carson William H.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Carson+William+H./17867277.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Carson+William+H./17867277.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Carson+William+H./17867277.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: Dai Yong</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Dai+Yong/17867272.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Dai+Yong/17867272.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Dai+Yong/17867272.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
  <item>
   <title>Form  4          Prevail Therapeutics      For: Jan 22  Filed by: Hefti Franz</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Hefti+Franz/17867258.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Hefti+Franz/17867258.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Prevail+Therapeutics++++++For%3A+Jan+22++Filed+by%3A+Hefti+Franz/17867258.html</guid>
   <pubDate>Tue, 26 Jan 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRVL</category>
   	  </item>
 </channel>
</rss>
